Letrozole and ribociclib and Mogamulizumab-kpkc Intravenous
Determining the interaction of Letrozole and ribociclib and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: n.a.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Letrozole and ribociclib-Molindone
- Letrozole and ribociclib-Mometasone (Oral Inhalation)
- Letrozole and ribociclib-Mometasone and Formoterol
- Letrozole and ribociclib-Mometasone and formoterol Inhalation
- Letrozole and ribociclib-Mometasone Cream
- Letrozole and ribociclib-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Leucovorin
- Mogamulizumab-kpkc Intravenous-Leucovorin Calcium
- Mogamulizumab-kpkc Intravenous-Leucovorin injection
- Mogamulizumab-kpkc Intravenous-Leucovorin Oral, Intravenous, Injection
- Mogamulizumab-kpkc Intravenous-Leucovorin Tablets
- Mogamulizumab-kpkc Intravenous-Leukeran